scholarly journals Mammographic texture resemblance generalizes as an independent risk factor for breast cancer

2014 ◽  
Vol 16 (2) ◽  
Author(s):  
Mads Nielsen ◽  
Celine M Vachon ◽  
Christopher G Scott ◽  
Konstantin Chernoff ◽  
Gopal Karemore ◽  
...  
2011 ◽  
Vol 284 (5) ◽  
pp. 1271-1276 ◽  
Author(s):  
Lakymê Ângelo Mangueira Porto ◽  
Karla Jamille Bezerra Lora ◽  
Juliana Coutinho Miranda Soares ◽  
Laura Olinda Bregieiro Fernandes Costa

2001 ◽  
Vol 27 (5) ◽  
pp. 464-471 ◽  
Author(s):  
Hark K. Kim ◽  
In-A. Park ◽  
Dae S. Heo ◽  
Dong-Y. Noh ◽  
Kuk-J. Choe ◽  
...  

2021 ◽  
Author(s):  
zhenfeng guan ◽  
yi sun ◽  
liang mu ◽  
yazhuo jiang ◽  
Jinhai fan

Abstract Bladder cancer (BCa) is an unfortunately critical genitourinary tract disease with an uncertain pathology. Increasing evidence indicates that the tumor microenvironment is decisive with respect to cancer progression, and that this is driven by tumor cell interactions with stromal components. Tenascin-C (TN-C) is an important extracellular matrix (ECM) component and TN-C has been reported to be involved in other cancers, i.e. breast cancer. Expression of TN-C in BCa tissue is reported to positively correlate to BCa pathologic grade, yet the presence of urine TN-C is regarded as an independent risk factor for BCa. Thus, we assessed the value of TN-C in BCa tissues and noted that it also was increased according to tumor grade and was an independent risk factor for BCa. In fact, TN-C contributes to BCa cell migration, invasion and proliferation and this is dependent on syndecan-4 and involves NF-κB signaling activation. How syndecan-4 is linked to activation of NF-κB signaling is unclear. Our data provide a foundation for future investigations into TN-C’s contribution to BCa progression.


2015 ◽  
Vol 151 (3) ◽  
pp. 569-576 ◽  
Author(s):  
Christoph Scholz ◽  
U. Andergassen ◽  
P. Hepp ◽  
C. Schindlbeck ◽  
Thomas W. P. Friedl ◽  
...  

2011 ◽  
Vol 35 (4) ◽  
pp. 381-387 ◽  
Author(s):  
M. Nielsen ◽  
G. Karemore ◽  
M. Loog ◽  
J. Raundahl ◽  
N. Karssemeijer ◽  
...  

Author(s):  
Paola Taroni ◽  
Anna Maria Paganoni ◽  
Francesca Ieva ◽  
Francesca Abbate ◽  
Enrico Cassano ◽  
...  

2021 ◽  
Author(s):  
Gregory Veillette ◽  
Maria Castaldi ◽  
Sacha A Roberts ◽  
Afshin Parsikia ◽  
Ankur Choubey ◽  
...  

Abstract Purpose The incidence of breast cancer (BC) in solid organ transplant recipients is comparable to the age-matched general population. It is among the three top-most commonly occurring cancers in women after liver transplantation (LT). There is limited information on the management and outcomes of breast cancer in liver transplant recipients (LTR). We aim to evaluate the impact of LT on breast cancer surgery outcomes. Further we compare the outcomes after breast cancer surgery in LTR in transplant versus non-transplant centers. Methods National Inpatient Sample (NIS) database was accessed to identify LTR with BC. Mortality, complications, hospital charges and total length of stay (LOS) were evaluated with multivariate logistic regression testing. Weighted multivariate regression models were employed to compare outcomes at transplant and non-transplant centers. Results Ninety-nine women met inclusion criteria for LT + BC and were compared against a cohort of women with BC without LT (n = 736,527). LT + BC had lower performance status as confirmed via higher Elixhauser Comorbidity Index (20.5% vs.10.2%, p < 0001). There were significantly more complications in the LT cohort when compared to the non-LTR (15.0% vs. 8.2%, p = 0.012). However, on multivariate analysis, LT was not an independent risk factor for post-operative complications following breast cancer surgery (OR 1.223, p = 0.480). Cost associated with breast cancer care was significantly higher in those with LT (2.621, p < 0.001). Breast conservation surgery in LT had shorter LOS as compared to BC alone (OR 0.568, p 0.027) in all hospitals. Conclusion LT does not increase short-term mortality when undergoing breast cancer surgery. Although there were significantly more complications in the LT cohort when compared to the non-LTR (15.0% vs. 8.2%, p = 0.012), on multivariate analysis, LT was not an independent risk factor for post-operative complications following breast cancer surgery. Additionally, breast cancer treatment is more costly in LTR.


Sign in / Sign up

Export Citation Format

Share Document